|
Volumn 28, Issue 6, 1996, Pages 3096-3098
|
Immunosuppression and immunomodulation of experimental models of systemic lupus erythematosus and antiphospholipid syndrome
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
BROMOCRIPTINE;
CYCLOSPORIN A;
HEPARIN;
IDIOTYPIC ANTIBODY;
IMMUNOGLOBULIN;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 3;
SEX HORMONE;
TAMOXIFEN;
THIAMAZOLE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIPHOSPHOLIPID SYNDROME;
BONE MARROW TRANSPLANTATION;
CONFERENCE PAPER;
DIET THERAPY;
DRUG RESEARCH;
EXPERIMENTAL MODEL;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
NONHUMAN;
PRIORITY JOURNAL;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ANIMALS;
ANTIBODIES;
ANTIGENS, CD4;
ANTIPHOSPHOLIPID SYNDROME;
DISEASE MODELS, ANIMAL;
FATTY ACIDS, OMEGA-3;
IMMUNOSUPPRESSION;
IMMUNOTHERAPY;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
METHIMAZOLE;
MICE;
MICE, INBRED BALB C;
NUTRITIONAL STATUS;
TAMOXIFEN;
|
EID: 0029826211
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (11)
|
References (0)
|